e.g. Tata motors, Reliance MF, 500570

Marksans Pharma Ltd. - Research Center

524404 MARKSANS Group (A) BSE data
 
Back to Company Page
Statement:

Cash flow

(Rs crore)
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20
Profit before tax 171.89 132.04 134.51 124.33 52.73
Net cashflow-operating activity 34.05 51.73 50.97 107.07 118.01
Net cash used in investing activity -114.22 -194.62 -8.40 8.82 -24.10
Netcash used in fin. activity -26.22 210.02 75.86 -13.53 -92.29
Net inc/dec in cash and equivlnt -106.38 67.12 118.44 102.36 1.63
Cash and equivalnt begin of year 148.31 81.19 105.61 3.35 1.12
Cash and equivalnt end of year 41.93 148.31 224.05 105.71 2.75
Close
Add Marksans Pharma Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Marksans Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback